Post the emergence of the Universal Wellbeing Model (UWM) in 2023, from an evidence-based multi-disciplinary and authentically holistic paradigm, the Universal Wellbeing Evaluation Tool (UWET) was developed. This quantitative tool supports users to self-assess, using a 5 point Likert scale, and identify: the status of each of the 70 Determinants of Universal Wellbeing; social physical, intellectual, ethnic, cultural, emotional and spiritual dimension levels; home, work and /or study environment impacts on overall Universal Wellbeing plus the Universal Wellbeing Risk level of the person completing the UWET.
The UWET uses an applied psychology approach, it empowers users to identify their strengths and capabilities, determinants of no influence, as well as those that could be, or are harming the users overall Universal Wellbeing. Learning about the UWM, what Universal Wellbeing is and then experiencing using the tool and understanding one's own unique personal Universal Wellbeing Profile collectively contribute to the acquisition of Universal Wellbeing Literacy. Professionally accredited UWET Facilitators administer, analyse, and report UWET outcomes to individuals and organisations using powerful strategies that optimises and accelerate the acquisition of personally relevant and meaningful Universal Wellbeing Literacy.
Informed by a clear theory of change, with impenetrability, and transformative learning at its heart; gaining Universal Wellbeing Literacy has been shown in early research trials to provide rich and applied learning experiences that support behaviour changes and personal transformations. The UWET is a core element in three research interventions that have been or are being trialled to measurably improve participation, achievement, productivity and equity levels in diverse settings. Higher education trials have consistently shown 30% plus increases in programme completion rates. The digitisation of the tool has made international Tool and intervention trialling possible at scale. Currently increasing access and conducting tool and intervention trials with diverse populations and randomised control trials is a priority.